4.5 Article

Decreased levels of alpha synuclein in families with autism spectrum disorder and relationship between the disease severity

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

Spatial and Temporal Gene Function Studies in Rodents: Towards Gene-Based Therapies for Autism Spectrum Disorder

Iris W. Riemersma et al.

Summary: Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by differences in social interaction, repetitive behaviors, restricted interests, and sensory differences. It is highly heterogeneous in terms of clinical presentation, genetics, and developmental trajectories. Over a thousand genes have been implicated in ASD, leading to the generation of numerous genetic mouse models. Identifying spatial and temporal gene functions in relation to the ASD phenotype is crucial, as is finding common biological processes modulated by ASD-related genes for patient stratification and personalized treatments.

GENES (2022)

Article Neurosciences

Somatosensory cortex hyperconnectivity and impaired whisker-dependent responses in Cntnap2-/- mice

Luigi Balasco et al.

Summary: Sensory abnormalities are common in individuals with autism spectrum disorders (ASDs). A study found that mice lacking the ASD-associated gene Cntnap2 display altered somatosensory processing and deficits related to core symptoms of ASDs. The study suggests that these mice can serve as a reliable model to study sensory abnormalities in ASDs.

NEUROBIOLOGY OF DISEASE (2022)

Review Psychiatry

Genetics of autism spectrum disorder: an umbrella review of systematic reviews and meta-analyses

Shuang Qiu et al.

Summary: This article presents an umbrella review of genetic studies on autism spectrum disorder (ASD) and provides a comprehensive overview of the risk genes associated with ASD. The study identifies significant single nucleotide polymorphisms (SNPs) in genes such as CNTNAP2, MTHFR, OXTR, SLC25A12, and VDR that may confer ASD risks. The findings offer evidence-based information for clinicians and healthcare decision-makers, guiding future treatment, prevention, and research.

TRANSLATIONAL PSYCHIATRY (2022)

Review Neurosciences

A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder

Sushmitha S. Purushotham et al.

Summary: Intellectual disability (ID) and autism spectrum disorder (ASD) are neurodevelopmental disorders with a prevalence of 2-3% in the population. Research on genetic variations associated with ID/ASD has progressed, but the understanding of the underlying molecular mechanisms and their connection to the pathogenic genes is still limited. This review explores the potential of identifying common molecular causes for ID/ASD based on available models and discusses biomarkers, drug failures in clinical trials, and therapeutic strategies beyond specific mutations.

EXPERIMENTAL BRAIN RESEARCH (2022)

Review Neurosciences

A systematic review of common genetic variation and biological pathways in autism spectrum disorder

Diego Alejandro Rodriguez-Gomez et al.

Summary: Among the biological processes examined, genes involved in synaptic integrity, neurotransmitter metabolism, and cell adhesion molecules were significantly associated with the development of autism. The over-representation analysis using the KEGG pathway database revealed enriched pathways related to neurotransmitter receptors and their subunits. Key biological processes included social behavior, vocalization behavior, learning, and memory. The cellular components of proteins encoded by the genes identified in this systematic review were primarily the postsynaptic membrane and cell junction.

BMC NEUROSCIENCE (2021)

Article Medicine, General & Internal

Plasma Levels of Alpha and Gamma Synucleins in Autism Spectrum Disorder: An Indicator of Severity

Sarah Al-Mazidi et al.

Summary: The study revealed that plasma levels of alpha-synuclein were significantly higher in children with autism spectrum disorder (ASD) compared to control children, while levels of gamma-synuclein were decreased in the ASD group. Furthermore, both alpha-synuclein and gamma-synuclein levels were found to be significantly associated with the severity of ASD.

MEDICAL PRINCIPLES AND PRACTICE (2021)

Review Neurosciences

Neuropathology and molecular diagnosis of Synucleinopathies

Shunsuke Koga et al.

Summary: Synucleinopathies are a group of diseases characterized by pathological aggregates of alpha-synuclein in neurons and glia. The two main disease entities are Lewy body disease and multiple system atrophy, each with different clinical subtypes. Currently, there are no disease-modifying therapies, but research on molecular mechanisms provides hope for future treatments.

MOLECULAR NEURODEGENERATION (2021)

Review Health Care Sciences & Services

Molecular Dysregulation in Autism Spectrum Disorder

Pritmohinder S. Gill et al.

Summary: Autism Spectrum Disorder (ASD) is a group of neurodevelopmental disorders with a strong genetic component, diagnosed mainly through behavioral criteria. Genomic analysis has identified many candidate genes associated with ASD risk, including rare and common variants. Rare mutations, copy number variations, and SNPs have been shown to impact neurodevelopment signaling.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Neurosciences

Disregulation of Autophagy in the Transgenerational Cc2d1a Mouse Model of Autism

Halime Dana et al.

NEUROMOLECULAR MEDICINE (2020)

Article Multidisciplinary Sciences

A heritable profile of six miRNAs in autistic patients and mouse models

Yusuf Ozkul et al.

SCIENTIFIC REPORTS (2020)

Review Biochemistry & Molecular Biology

α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis

Surabhi Mehra et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)

Article Neurosciences

Cerebrospinal Fluid and Plasma Biomarkers in Neurodegenerative Diseases

Yusuke Seino et al.

JOURNAL OF ALZHEIMERS DISEASE (2019)

Article Biochemistry & Molecular Biology

Altered Global mRNA Expressions of Pain and Aggression Related Genes in the Blood of Children with Autism Spectrum Disorders

Elif Funda Sener et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2019)

Article Biotechnology & Applied Microbiology

Significant Changes in Plasma Alpha-Synuclein and Beta-Synuclein Levels in Male Children with Autism Spectrum Disorder

Wilaiwan Sriwimol et al.

BIOMED RESEARCH INTERNATIONAL (2018)

Review Psychiatry

Anxiety Disorders and Obsessive-Compulsive Disorder in Individuals with Autism Spectrum Disorder

Valentina Postorino et al.

CURRENT PSYCHIATRY REPORTS (2017)

Review Clinical Neurology

Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review

Clarissa Loureiro das Chagas Campelo et al.

PARKINSONS DISEASE (2017)

Article Biochemistry & Molecular Biology

CADPS2 gene expression is oppositely regulated by LRRK2 and alpha-synuclein

Julia Obergasteiger et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Endocrinology & Metabolism

The roles of CC2D1A and HTR1A gene expressions in autism spectrum disorders

Elif Funda Sener et al.

METABOLIC BRAIN DISEASE (2016)

Article Clinical Neurology

Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan

Christine Ecker et al.

LANCET NEUROLOGY (2015)

Article Clinical Neurology

Low Serum Level α-Synuclein and Tau Protein in Autism Spectrum Disorder Compared to Controls

Muhammed Tayyib Kadak et al.

NEUROPEDIATRICS (2015)

Article Psychology, Clinical

The epidemiology and global burden of autism spectrum disorders

A. J. Baxter et al.

PSYCHOLOGICAL MEDICINE (2015)

Review Neurosciences

Brain disposition of α-Synuclein: roles of brain barrier systems and implications for Parkinson's disease

Christopher A. Bates et al.

FLUIDS AND BARRIERS OF THE CNS (2014)

Review Cell Biology

Alpha-synuclein: from secretion to dysfunction and death

O. Marques et al.

CELL DEATH & DISEASE (2012)

Review Biochemistry & Molecular Biology

The role of alpha-synuclein in neurotransmission and synaptic plasticity

Furong Cheng et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2011)

Article Neurosciences

Plasma α-synuclein is decreased in subjects with Parkinson's disease

Qiao-Xin Li et al.

EXPERIMENTAL NEUROLOGY (2007)